SPDR S&P Pharmaceuticals ETF
XPH
XPH
60 hedge funds and large institutions have $156M invested in SPDR S&P Pharmaceuticals ETF in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 18 increasing their positions, 23 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
77% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 13
Holders
60
Holding in Top 10
–
Calls
$4K
Puts
–
Top Buyers
| 1 | +$2.83M | |
| 2 | +$1.45M | |
| 3 | +$775K | |
| 4 |
WBG
Wharton Business Group
Malvern,
Pennsylvania
|
+$215K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$200K |
Top Sellers
| 1 | -$81.8M | |
| 2 | -$18.8M | |
| 3 | -$4.79M | |
| 4 |
SG Americas Securities
New York
|
-$4.11M |
| 5 |
Citigroup
New York
|
-$2.1M |